BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11596015)

  • 41. Successfully-treated mesenteric non-Hodgkin's lymphoma involving hepatic mass--a case report.
    Yamaguchi T; Takahashi H; Kagawa R; Takeda R; Sakata S; Yamamoto M; Nishizaki D; Takamatsu T; Iwasa Y
    Gan To Kagaku Ryoho; 2007 May; 34(5):783-7. PubMed ID: 17496458
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET.
    Halasz LM; Jacene HA; Catalano PJ; Van den Abbeele AD; Lacasce A; Mauch PM; Ng AK
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e647-54. PubMed ID: 22607911
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Primary lymphoma of the kidney. Report of a case and update of the literature.
    Porcaro AB; D'Amico A; Novella G; Curti P; Ficarra V; Antoniolli SZ; Martignoni G; Matteo B; Malossini G
    Arch Ital Urol Androl; 2002 Mar; 74(1):44-7. PubMed ID: 12053451
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of two different ProMACE-CytaBOM derived regimens in advanced aggressive non-Hodgkin's lymphoma. Final report of a multicenter trial conducted by GISL.
    Federico M; Clò V; Brugiatelli M; Carotenuto M; Gobbi PG; Vallisa D; Lombardo M; Avanzini P; Di Renzo N; Dini D; Baldini L; Silingardi V
    Haematologica; 1998 Sep; 83(9):800-11. PubMed ID: 9825577
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A case of primary hepatic non-Hodgkin's lymphoma with chronic hepatitis C.
    Kaneko F; Yokomori H; Sato A; Takeuchi H; Tahara K; Sekiguchi Y; Mori S; Motoori T; Kondo H; Hibi T
    Med Mol Morphol; 2008 Sep; 41(3):171-4. PubMed ID: 18807144
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatitis C reactivation in patients who have diffuse large B-cell lymphoma treated with rituximab: a case report and review of literature.
    Nooka A; Shenoy PJ; Sinha R; Lonial S; Flowers CR
    Clin Lymphoma Myeloma Leuk; 2011 Oct; 11(5):379-84. PubMed ID: 21729690
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Prognosis of primary non-Hodgkin's lymphoma of the breast].
    Guo HY; Zhao XM; Cao JN; Hu XC; Yin JL; Hong XN; Li J
    Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):200-2. PubMed ID: 18756936
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Primary lymphoma of the prostate: good outcome with doxorubicin-based combination chemotherapy.
    Sarris A; Dimopoulos M; Pugh W; Cabanillas F
    J Urol; 1995 Jun; 153(6):1852-4. PubMed ID: 7752334
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma.
    Gordon LI; Harrington D; Andersen J; Colgan J; Glick J; Neiman R; Mann R; Resnick GD; Barcos M; Gottlieb A
    N Engl J Med; 1992 Nov; 327(19):1342-9. PubMed ID: 1383819
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primary extranodal non-Hodgkin's lymphoma: clinicopathological features, survival and treatment outcome in two cancer centers of southern Turkey.
    Mertsoylu H; Muallaoglu S; Besen AA; Erdogdu S; Sezer A; Sedef AM; Kose F; Arican A; Ozyilkan O
    Asian Pac J Cancer Prev; 2014; 15(17):7207-11. PubMed ID: 25227815
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
    Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
    Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-Hodgkin's lymphoma.
    McMaster ML; Greer JP; Wolff SN; Johnson DH; Greco FA; Stein RS; Cousar JB; Flexner JM; Hainsworth JD
    Cancer; 1991 Jul; 68(2):233-41. PubMed ID: 1712662
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/ HBcAb-positive: a multicenter retrospective study.
    Ji D; Cao J; Hong X; Li J; Wang J; Chen F; Wang C; Zou S
    Eur J Haematol; 2010 Sep; 85(3):243-50. PubMed ID: 20491883
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.
    Vaccher E; Spina M; di Gennaro G; Talamini R; Nasti G; Schioppa O; Vultaggio G; Tirelli U
    Cancer; 2001 Jan; 91(1):155-63. PubMed ID: 11148572
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic role of serum lactate dehydrogenase beyond initial diagnosis: a retrospective analysis of patients with diffuse large B cell lymphoma.
    Hong J; Yoon HH; Ahn HK; Sym SJ; Park J; Park PW; Ahn JY; Park S; Cho EK; Shin DB; Lee JH
    Acta Haematol; 2013; 130(4):305-11. PubMed ID: 24008775
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Primary hepatic lymphoma.
    Padhan RK; Das P; Shalimar
    Trop Gastroenterol; 2015; 36(1):14-20. PubMed ID: 26591949
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d'Etude des Lymphomes de l'Adulte.
    Wendum D; Sebban C; Gaulard P; Coiffier B; Tilly H; Cazals D; Boehn A; Casasnovas RO; Bouabdallah R; Jaubert J; Ferrant A; Diebold J; de Mascarel A; Gisselbrecht C
    J Clin Oncol; 1997 Apr; 15(4):1654-63. PubMed ID: 9193366
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B.
    Todeschini G; Secchi S; Morra E; Vitolo U; Orlandi E; Pasini F; Gallo E; Ambrosetti A; Tecchio C; Tarella C; Gabbas A; Gallamini A; Gargantini L; Pizzuti M; Fioritoni G; Gottin L; Rossi G; Lazzarino M; Menestrina F; Paulli M; Palestro M; Cabras MG; Di Vito F; Pizzolo G
    Br J Cancer; 2004 Jan; 90(2):372-6. PubMed ID: 14735179
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Treatment of primary mediastinal large B-cell lymphomas].
    Schneider T; Tóth E; Molnár Z; Várady E; Deák B; Horváth A; Horváth GI; Eid H; Schneider K; Lovey J; Keresztes S; Esik O; Lengyel Z; Rosta A
    Orv Hetil; 2004 Dec; 145(50):2531-7. PubMed ID: 15662753
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical characteristics and prognosis of diffuse large B-cell lymphoma].
    Yang BY; Yong WB; Zhu J; Zheng W; Zhang YT; Wang XP; Meng SN
    Zhonghua Zhong Liu Za Zhi; 2005 Mar; 27(3):174-6. PubMed ID: 15946571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.